secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001640334-25-000732
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences raises $900k via convertible notes with 12% interest and warrants
--------------------------------------------------------------------------------

- Closed $900,000 convertible note offering; directors and management purchased $200,000 of the notes.
- Notes carry 12% annual interest (20% on default), mature in 180 days; voluntary conversion at $1.29/share.
- Unconverted principal automatically converts to warrants at $0.125/share; exercise price $1.04/share.
- Warrants have 5-year term, cashless exercise option, and standard anti-dilution provisions.
- Company commits to file resale registration statement for underlying shares within 45 days after maturity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425000732/0001640334-25-000732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425000732/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-000732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer